Skip to main content
HR 2951 112th Congress House

Patients First Act of 2011

Official title: To intensify stem cell research showing evidence of substantial clinical benefit to patients, and for other purposes.

Introduced: September 15, 2011 See on congress.gov
Health Administrative law and regulatory proceduresCell biology and embryologyDepartment of Health and Human ServicesGovernment studies and investigations
More subjectsShow fewer subjects
Medical ethicsMedical researchResearch administration and funding
This bill died when the 112th Congress ended
It never became law before the 112th Congress (2011–2012) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 20, 2011
Referred to the Subcommittee on Health.
Sep 15, 2011
Referred to the House Committee on Energy and Commerce.
Sep 15, 2011
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action September 20, 2011

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Patients First Act of 2011 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions, including pluripotent stem cells that have the flexibility of embryonic stem cells (whether or not such pluripotent stem cells have an embryonic source), provided that such techniques will not involve: (1) the creation of a human embryo for research purposes; (2) the destruction or discarding of, or risk of injury to, a living human embryo; or (3) the use of any stem cell the derivation or provision of which would be inconsistent with this Act.

Requires the Secretary to issue guidelines implementing this Act to ensure that any research (including any clinical trial) supported under this Act: (1) is clearly consistent with the standards established in this Act, if conducted using human cells; and (2) is prioritized in terms of potential for near-term clinical benefit in human patients.

Requires the Secretary to report on peer reviewed stem cell research proposals that were not funded.

 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2951: Patients First Act of 2011. 112th Congress. Open America. https://openamerica.io/bill/112-HR-2951/
MLA
"H.R. 2951: Patients First Act of 2011." 112th Congress, 2026, Open America, https://openamerica.io/bill/112-HR-2951/.
Bluebook (legal)
H.R. 2951, 112th Cong. (2026), https://openamerica.io/bill/112-HR-2951/.
Markdown link
[H.R. 2951: Patients First Act of 2011](https://openamerica.io/bill/112-HR-2951/)
Report a problem